Viewing Study NCT00161759


Ignite Creation Date: 2025-12-24 @ 2:33 PM
Ignite Modification Date: 2026-01-24 @ 11:47 PM
Study NCT ID: NCT00161759
Status: COMPLETED
Last Update Posted: 2006-10-20
First Post: 2005-09-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds
Sponsor: Baxter Healthcare Corporation
Organization:

Study Overview

Official Title: A Study to Assess the Safety and Efficacy of Fibrin Sealant (FS 4IU) for Wound Healing in Subjects With Burn Wounds Requiring Skin Grafting Procedures
Status: COMPLETED
Status Verified Date: 2006-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to assess if Fibrin Sealant 4IU is as safe and efficacious as staples (the current standard of care) to achieve fixation of skin grafts and wound healing in subjects with burn wounds. Each subject receives staples as well as FS 4IU on comparable treatment sites.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: